Latest Series B Funding Rounds
Startups financing expansion after their early institutional rounds. Explore the businesses, round sizes and investors behind the next phase.
- Rounds
- 589 All time
- Disclosed funding
- $58.6B 500 disclosed amounts
- Median round
- $46.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
EpiBiologicsCompany profile Develops bispecific antibodies for targeted degradation of extracellular proteins. Develops bispecific antibodies for targeted degradation of extracellular proteins. | $107M | Series B | Biotech | United States | Investors | |
| A Develops specialized AI systems for regulated industries | $70M | Series B | AI | United States | Investors | |
Nocion TherapeuticsCompany profile Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. | $23M | Series B+Series B | Biotech | United States | Investors Undisclosed | |
| MT Develops therapies to halt fibrosis in multiple organ systems | $76M | Series B | Biotech | United States | Investors | |
| G GSMECompany profile Provides semiconductor services including chip design, manufacturing, and supply chain visibility Provides semiconductor services including chip design, manufacturing, and supply chain visibility | $35M | Series B | Hardware | United States | Investors | |
| Q Develops ultra-low-power GNSS and IoT chips for connected edge applications | €20M | Series B | Space tech | Netherlands | Investors | |
CambiumCompany profile Cambium develops advanced materials for defense, aerospace and other high-performance applications using AI. Cambium develops advanced materials for defense, aerospace and other high-performance applications using AI. | $100M | Series B | Industrial tech | United States | Investors | |
| N Neeman’sCompany profile Neeman’s sells everyday footwear through its online store and retail network. Neeman’s sells everyday footwear through its online store and retail network. | ~₹355M | Series B2Series B | Consumer | India | Investors | |
| SB Surv BioPharma develops oncolytic virus therapies for cancer. | ¥670M | Series B second closeSeries B | Biotech | Japan | Investors | |
| D DigantaraCompany profile Digantara develops space-surveillance and intelligence systems for government and commercial customers. Digantara develops space-surveillance and intelligence systems for government and commercial customers. | $50M | Series B | Space tech | India | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Model ML, Garage, Infisical
23rounds0led - 2General Catalyst
Rox, Hypersonica, Collective
23rounds8led - 3Khosla Ventures
Traversal, Even Healthcare, Arena
23rounds6led - 4Andreessen Horowitz (a16z)
Tutor Intelligence, Town, Arena
22rounds4led - 5Sequoia Capital
Rox, Traversal, Nevis
20rounds4led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.